Henderson Group »

Atrium Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 140k 13.37

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics